Risk Factors Associated with Reoperation for Bleeding following Liver Transplantation
Table 2
Characteristics of the liver transplant operation.
Variable
Reoperation for bleeding
Control group
value
Operation length (min)
269.8 ± 119.6
278.2 ± 104.9
0.50
Cold ischemia time (min)
405.5 ± 166.9
390.8 ± 174.4
0.41
Warm ischemia time (min)
49.3 ± 45.7
47.9 ± 18.4
0.46
Transfusiona
Red blood cells (units)
4.3 ± 4.2
3.7 ± 3.5
0.19
Fresh frozen plasma (units)
1.8 ± 2.6
1.5 ± 1.8
0.19
Platelets (units)
1.1 ± 1.4
1.9 ± 3.7
<0.001
Cryo administered (%)
4.49
1.33
0.05
Last fibrinogen level
151.8 ± 107.4
124.6 ± 49.6
0.22
Estrogen administered (%)
26.97
35.37
0.11
Amicar administered (%)
20.22
30.19
0.05
Epigastric surgical history (%)
24.8
24.2
0.91
Vascular reconstructionb (%)
1.0
4.4
0.17
Retransplant (%)
5.0
4.3
0.80
Data presented as percent or mean ± standard deviation.
aBlood products transfused only during the liver transplant operation do not include data on reoperation for bleeding.
bIncludes both arterial conduits and mesenteric venous bypass grafts.
